Decision Making Process in Patients with Early Stage Prostate Cancer and Their Partners/Close Allies

Inclusion Criteria

• PATIENTS: Men with low risk prostate cancer who meet the following criteria: * Most recent Gleason score =< 6 OR clinical stage T1c or less * Most resent prostate specific antigen (PSA) level below 10 OR the patient's doctor discussed active surveillance as a treatment option (as documented in visit notes of the patient's medical record)
• PATIENTS: Are able to speak, read, write and understand English well enough to provide informed consent and complete study tasks
• PATIENT: Has not made a treatment decision prior to consent, as per self report
• PARTNERS/CLOSE ALLIES: Considered a partner/close ally to the patient in the treatment making decision, as reported by the patient
• PARTNERS/CLOSE ALLIES: Are able to speak, read, write and understand English well enough to provide informed consent and complete study tasks
• PARTNERS/CLOSE ALLIES: 18 years or older

Exclusion Criteria

• PATIENTS: History of a cancer other than prostate cancer and non-melanoma skin cancer
• PATIENTS: Significant psychiatric or cognitive disturbance sufficient, in the investigator's judgment, to preclude providing informed consent or participating in the study activities (i.e., acute psychiatric symptoms which require individual treatment)
• PARTNERS/CLOSE ALLIES: Significant psychiatric or cognitive disturbance sufficient, in the investigator's judgment, to preclude providing informed consent or participating in the study activities (i.e., acute psychiatric symptoms which require individual treatment)